April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.
June 17, 2020
Robust M&A displays value despite pushback.
May 14, 2020
The moral imperative to innovate.